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recommended by the guidelines to routinely monitor patients after atrial fibrillation 
(AF)	ablation.
Aims: To	validate	the	diagnostic	value	of	ILR	after	AF	ablation,	modern	generation	
ILRs	 (LINQ)	were	 implanted	 in	 patients	 scheduled	 for	 cryoballoon	 ablation	 of	 AF	
(CBA).
Methods: We included 29 patients with frequent and symptomatic episodes of par-
oxysmal	AF.	ILR	was	implanted	3	months	prior	to	CBA,	and	data	were	collected	be-
fore and for 6 months after the procedure. The device was programmed to maximize 
sensitivity	of	AF/	atrial	tachycardia	(AT)	detection.	All	EGM	recordings	were	“manu-
ally” assessed and annotated as true AF, pseudo AF, unrecognized AF, and episodes 
with	no	EGM	available.	Duration	and	episode-based	standard	performance	metrics	
were evaluated.
Results: A total number of 5,842 episodes were recorded. A total of 4,403 episodes 
were	true	AF,	453	episodes	were	pseudo	AF,	and	986	episodes	had	no	EGM	avail-
able. The device did not recognize 144 episodes of AF. Duration-based sensitivity 
was 95.2%, duration-based specificity 99.9%, duration-based PPV 99.2%, duration-
based	NPV	99.9%,	episode-based	sensitivity	98.0%,	and	episode-based	PPV	91.0%.	
Misdiagnosis happened in 1 in 10 episodes. Total data review time was 166 hr.
Conclusions: Implantable	 loop	recorders	 is	a	valuable	tool	 in	evaluation	of	AF	epi-
sodes in patients undergoing CBA. However, for high precision all recorded episodes 
need	to	be	evaluated	“manually.”	The	memory	storage	space	is	too	low	for	frequent	
AF	episodes,	resulting	in	overwriting	of	stored	EGMs	and	data	loss.
K E Y W O R D S
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1  | INTRODUC TION
Implantable	 loop	 recorders	 (ILR)	 are	 currently	 recommended	 in	
various clinical situations when long-term cardiac monitoring 
is needed. These devices have proven to be a useful tool in the 
diagnosis and treatment of heart palpitations, unexplained syn-
cope, cryptogenic stroke, or ventricular arrhythmias. They also 
seem to be the perfect method of monitoring patients undergo-
ing	atrial	 fibrillation	 (AF)	ablation	 (Pokushalov	et	al.,	2011;	Task	
Force	Members,	Brignole,	Vardas,	&	Hoffman,	22009).	For	obvi-
ous reasons, traditional methods of heart rhythm assessment as 
electrocardiogram	(ECG)	or	24-hr	Holter	monitoring	may	not	cap-
ture all AF episodes, with a considerable number of them being 
asymptomatic.	 It	 has	been	proven	 that	 the	 correlation	between	
symptoms	 and	 occurrence	 of	 AF	 is	 poor	 (Verma	 et	 al.,	 2013).	
Although	ILRs	are	not	currently	recommended	by	the	guidelines	
to routinely monitor patients undergoing AF ablation, this looks 
like a promising method to precisely assess the AF recurrence 
rate after procedure. Accurate information regarding arrhythmia 
episodes, arrhythmia types, and correlation with symptoms could 
help indicate patients who need redo ablation and guide phar-
macological	treatment.	To	validate	the	clinical	value	of	ILR	after	
AF ablation, we decided to implant modern generation devices in 







degrees to the sternal border, as instructed by the manufacturer. The 
incision and insertion tools supplied by the manufacturer were used. 






programmed as follows: AT/AF episodes = ALL, sensitivity = 35 µV and 
blanking	=	150	ms,	“ectopy	rejection”	algorithm	=	disabled.	The	device	
makes a rhythm classification every 2 min; therefore, it is able to detect 
AF lasting at least 2 min. Up to 14 episodes of AF can be stored with 
ECG	 tracing;	 afterward,	 the	 earliest	 episode	 is	 overwritten	 by	most	
recent episodes. The longest AF episode is always preserved. The 
transmission of episodes from device memory was conducted daily 
via remote monitoring system. The device was able to record pauses 
with	time	duration	longer	than	3	s.	In	case	of	symptoms,	patient	could	
manually	activate	the	ILR	with	a	remote	controller	and	store	up	to	4	
episodes with time duration of 7.5 min (1 min prior and 6.5 min after 
device	activation).
Cryoballoon ablation of pulmonary vein antra was performed 
under conscious sedation according to a standardized protocol. Briefly, 
after a single transseptal puncture with a Brockebrough needle each 
vein was occluded with the 28 mm cryoballoon (Arctic Front Advance, 
Medtronic	 Inc)	 under	 fluoroscopic	 visualization	 and	 with	 occlusion	
confirmed with the contrast method. Two 240-s freezes were applied 
per vein, or more, if vein was not isolated with the first freeze; this was 
assessed	with	a	circular	catheter	(Achieve,	Medtronic	Inc)	using	LAB	
System	Pro	electrophysiology	system	(Boston	Scientific).
All patients were supplied with remote monitoring system 
(MyCareLink™,	 Medtronic	 Inc).	 Data	 stored	 by	 the	 device	 were	
daily sent to the Carelink® web system. All data were evaluated on 
day-to-day	basis	by	a	clinician.	ECG	recordings	of	all	AF	episodes	
that	were	registered	automatically	and	also	ECGs	of	symptom-re-
lated events were assessed and annotated as true AF or pseudo 
AF. All recordings were independently reviewed by two cardiolo-
gists, and in case of disagreement, third expert electrophysiologist 
was consulted.
2.1 | Statistical analysis
All episodes lasting at least 2 min were analyzed and divided into true 
AF,	false	AF,	unrecognized	AF,	and	episodes	with	no	EGM	available.	
What's new?
• For the first time, such a large number of arrhythmia epi-
sodes have been evaluated automatically by the device 
and verified by an observer.
• We showed that the data gathered by the device can-
not be fully trusted as misclassifications were not 
infrequent.
•	 Some	unique	ILR	recordings	are	presented.




















98.0   
Episode-based	PPV	(%) 91.0   
Abbreviations:	CBA,	cryoballoon	ablation;	NPV,	negative	predictive	
value; PPV, positive predictive value.
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Duration and episode-based standard performance metrics (sen-
sitivity, specificity, positive predictive value [PPV], and negative 
predictive	 value	 [NPV])	were	 evaluated	 (Table	 1.).	Duration-based	
metrics	 were	 calculated	 using	 time	 duration	 of	 true-positive	 (TP),	
true-negative	(TN),	false-positive	(FP),	and	false-negative	(FN)	atrial	
fibrillation	episodes.	Episode-based	metrics	calculated	 the	propor-
tion of true episodes and episodes unrecognized by the device. 
Episode	PPV	was	calculated,	but	no	NPV	could	be	established,	 as	
a	 true-negative	 episode	 cannot	 be	 defined	 (Sanders	 et	 al.,	 2016).	










Twenty-nine patients with paroxysmal atrial fibrillation resistant to 
antiarrhythmic drug therapy were included into the study (20 men, 
mean	age	55.6	years	old,	range	34–72).	All	patients	had	uneventful	
ILR	insertion	and	successful	CBA	(all	4	veins	were	isolated	in	every	
patient).	 CBA	 resulted	 in	 significant	 reduction	 of	 AF	 burden	 from	
9.4% to 0.2%; the baseline characteristics of the enrolled patients 
and CBA outcomes are listed in Table 2.





Therefore, the final number of AF true-positive episodes that were 
possible	to	evaluate	was	4,403	(8,222.6	hr).	Additionally	in	144	epi-
sodes	(420.0	hr)	initially	diagnosed	by	the	ILR	as	AT,	the	final	diagno-
sis was changed to AF after evaluation.
The reason for incorrect diagnosis of AF was in most cases supra-
ventricular	 extrasystoles	 or	 external	 electric	 interference	 (noise)—
Figures 1, 2, and 3. There were also some episodes of T-wave 
oversensing	(Figure	4).	The	ILRs	had	mainly	difficulties	to	differenti-
ate arrhythmias in short episodes that lasted up to 4 min.




Patients were advised to send the data on daily basis, yet often 






The performance-based metrics are summarized in Table 1.
4  | DISCUSSION
In	the	current	study,	we	assessed	the	clinical	value	of	ILR	in	arrhyth-
mia monitoring and categorization in patients undergoing CBA and 
showed that approximately 10% of recorded arrhythmia episodes 
were misclassified by the automatic, device-based method. For pre-









device was active and the longer were the AF episodes, the better 
were	sensitivity	and	specificity.	In	our	study,	we	observed	patients	
with high number of AF episodes that transferred to large number 
of	EGMs.	This	might	be	the	reason	for	less	false-positive	episodes	
than	indicated	in	earlier	studies	(Damiano	et	al.,	2016).	To	make	the	
device more sensitive to AF, ectopy rejection algorithm was pro-
grammed	off.	In	our	study,	we	attempted	to	record	each	AF	episode,	
even the short ones. Based on our observations and large trials’ data 
(e.g.,	CASTLE-AF),	in	real-life	settings	not	every	patient	might	need	
that precise assessment. We would suggest to routinely activate the 
ectopy ejection function. Possibly with this feature turned on, the 
number of wrongly diagnosed episodes would be lower. However, 
the	ectopy	was	not	the	only	reason	the	ILR	was	not	able	to	correctly	
recognize AF episode. Based on our observations, there is no gen-
eral	ILR	setting	that	would	fit	all	patients;	the	programming	of	an	ILR	
should be tailored to a particular clinical situation.
Personal assessment of multiple episodes daily in several pa-
tients is extremely time-consuming. The assessment of all recorded 
episodes	 took	166	hr.	 In	other	words,	 time	needed	 to	evaluate	all	
TA B L E  2   The characteristics of the enrolled patients (n	=	29)





Coronary heart disease (n) 4	(14%)
Hypertension (n) 15	(52%)
Atrial fibrillation burden pre CBA 9.4%
Atrial fibrillation burden post-CBA 0.2%
Abbreviations: CBA, cryoballoon ablation; LV, left ventricle
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episodes in our study is equal to a week of constant work. Such a 




Moreover, limited storage capacity makes it impossible to 
evaluate	 all	 episodes.	 Even	 in	 patients	 conducting	 transmissions	
on daily basis, large number of episodes was overwritten by most 
recent ones. This problem could easily be solved by expanding the 
internal memory of the device. Another solution is to export the 
F I G U R E  1   Incorrectly	diagnosed	AF.	In	fact	sinus	rhythm	with	extrasystoles	and	some	noise
F I G U R E  2   Incorrect	diagnosis	of	AF	due	to	extrasystoles
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F I G U R E  3  Extrasystoles	diagnosed	as	AF
F I G U R E  4   Incorrect	diagnosis	of	AF	due	to	T-wave	oversensing—railroad	track	pattern
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stored data in simplified format possible to be analyzed off-line by 
other	algorithms.	With	no	recorded	EGMs,	there	is	no	possibility	
to	 verify	 diagnosis	made	by	 ILR,	 and	 as	we	 indicated,	 automatic	
diagnosis	could	not	be	fully	trusted.	One	of	possible	solutions	to	
this problem is to increase the device memory space. This would 
likely be beneficial for the patients, even if requires a moderate in-
crease in the size of the device. Another storage expanding possi-
bility is to collect and export raw data for further off-line analysis. 
The	ILR	seems	to	have	higher	accuracy	with	longer	episodes.	Most	
problems regarding incorrect diagnosis were with episodes lasting 
F I G U R E  5  Episode	of	AF	incorrectly	diagnosed	as	AT.	Two	short	episodes	of	AF	(<2	min)	present
F I G U R E  6  Patient-activated	recording	shows	AF	and	misdiagnosed	AT	(in	fact	AF)
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2 min. This observation is also in concordance with earlier studies 
(Sanders	et	al.,	2016).
Current	ESC	guidelines	define	episode	of	AF	as	lasting	at	least	
30	s	 (Lip	et	al.,	2019).	The	2-min	 loop	that	 is	used	to	check	heart	
rhythm	by	ILR	will	obviously	skip	some	short	episodes	of	arrhyth-
mia. Those short runs of AF are not uncommon. They were often 
recorded when patient pressed symptoms button, and the device 
stored	 longer	 EGM.	 It	 is	 also	 not	 possible	 to	 evaluate	 how	many	
clinically silent AF episodes lasting less than 2 min happened. 
Regarding issues with limited storage and inaccuracy when as-
sessing short episodes, it is still frustrating that some AF episodes 
remain undetected despite continuous monitoring. The clinical 
significance of short AF episodes remains uncertain (Steinberg, 
O’Connell,	Li,	&	Ziegler,	2018).	The	 total	number	of	AF	episodes,	
including these lasting less than 2 min, is definitely greater than 
indicated	by	the	ILRs.
4.1 | Clinical implications
The traditional methods of postablation AF recurrence assessment 
like	 arrhythmia-related	 symptoms,	 ECG,	 or	 24-hr	 ECG	monitoring	
seem	to	be	inadequate.	 It	has	already	been	proven	that	traditional	
follow-up methods overestimate AF ablation success rate by up to 
14%	 when	 compared	 to	 continuous	 monitoring	 with	 ILR	 (Gersak,	
Pernat,	Robic,	&	Sinkovec,	2012).
Our	observation	stands	in	line	with	previous	studies	showing	dra-
matic	 reduction	of	AF	burden	post-CBA.	 It	needs	 to	be	emphasized	
that the decision to ablate AF should be mainly based on the pres-
ence	of	arrhythmia	symptoms;	the	ILR	data	are	only	complementary.	
However,	ILR	data	can	explain	the	nature	of	patient	symptoms	by	pro-
viding a firm correlation; occasionally, AF-like symptoms are caused by 
a	different	arrhythmia	(mainly	atrial	extrasystoles	in	our	experience),	
and AF ablation/re-ablation would be a mistake. We believe that with 
10%	arrhythmia	misclassification	rate	by	the	ILR,	“manual”	verification	
of automatic arrhythmia categorization should be considered when 
important	decisions	are	made	on	the	basis	of	ILR	data.	With	reliable	
information regarding AF recurrences, it could be possible to decide in 
some patients with borderline CHA2DS2-VASc scale score whether the 
anticoagulation	therapy	should	be	continued	or	might	be	stopped.	It	is	
still debatable whether a male with 1 point or a female with 2 points 
in	that	scale	should	be	anticoagulated.	In	such	cases,	reliable	ILR	data	
could provide additional guidance. The same holds true for antiar-
rhythmic drugs use; accurate information about AF episodes, including 
asymptomatic ones, could guide optimal pharmacological treatment.
4.2 | Limitations
The main limitation of the study is relatively small study group. 
However, in study population there was a large number of observed 
episodes.
F I G U R E  7  Episode	of	AF	incorrectly	diagnosed	as	AT
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5  | CONCLUSIONS
ILR	 could	 be	 a	 valuable	 tool	 in	 AF	 burden	 assessment	 in	 patients	
undergoing CBA as it provides a detailed data about the arrhyth-
mia occurrence. However, manual verification of episodes should 
be	considered	in	some	cases,	as	AF	misdiagnosis	was	frequent—ob-
served by us in almost 10% of recorded episodes.
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